Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 22;9(1):62.
doi: 10.1186/s13550-019-0533-6.

Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy

Affiliations

Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy

Marilyne Kafrouni et al. EJNMMI Res. .

Abstract

Background: The aim of this study was to compare predictive and post-treatment dosimetry and analyze the differences, investigating factors related to activity preparation and delivery, imaging modality used, and interventional radiology.

Methods: Twenty-three HCC patients treated by selective internal radiation therapy with 90Y glass microspheres were included in this study. Predictive and post-treatment dosimetry were calculated at the voxel level based on 99mTc-MAA SPECT/CT and 90Y-microsphere PET/CT respectively. Dose distribution was analyzed through mean dose, metrics extracted from dose-volume histograms, and Dice similarity coefficients applied on isodoses. Reproducibility of the radiological gesture and its influence on dose deviation was evaluated.

Results: 90Y delivered activity was lower than expected in 67% (16/24) of the cases mainly due to the residual activity. A mean deviation of - 6 ± 11% was observed between the delivered activity and the 90Y PET's FOV activity. In addition, a substantial difference of - 20 ± 8% was measured on 90Y PET images between the activity in the liver and in the whole FOV. After normalization, 99mTc-MAA SPECT dosimetry was highly correlated and concordant with 90Y-microsphere PET dosimetry for all dose metrics evaluated (ρ = 0.87, ρc = 0.86, P = 3.10-8 and ρ = 0.91, ρc = 0.90, P = 7.10-10 for tumor and normal liver mean dose respectively for example). Besides, mean tumor dose deviation was lower when the catheter position was identical than when it differed (16 Gy vs. 37 Gy, P = 0.007). Concordance between predictive and post-treatment dosimetry, evaluated with Dice similarity coefficients applied on isodoses, significantly correlated with the distance of the catheter position from artery bifurcation (P = 0.04, 0.0004, and 0.05, for 50 Gy, 100 Gy, and 150 Gy isodoses respectively).

Conclusions: Discrepancies between planned activity and activity measured on 90Y PET images were observed and seemed to be mainly related to clinical hazards and equipment issues. Predictive vs. post-treatment comparison of relative dose distributions between tumor and normal liver showed a good correlation and no significant difference highlighting the predictive value of 99mTc MAA SPECT/CT-based dosimetry. Besides, the reproducibility of catheter tip position appears critical in the agreement between predictive and actual dose distribution.

Keywords: Dosimetry; Hepatocellular carcinoma; MAA; SIRT; Y-90 microspheres.

PubMed Disclaimer

Conflict of interest statement

MK received a research grant from DOSIsoft SA (Cachan, France) for her PhD. SV is an employee of DOSIsoft SA (Cachan, France). The other authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Relative difference between the activity measured in the whole FOV of 90Y-PET images and the delivered activity (a) and between the activity measured in the segmented liver and the whole FOV of 90Y-PET images (b), both as a function of BMI
Fig. 2
Fig. 2
Post-treatment vs. predictive dosimetry based on normalized 99mTc-MAA SPECT and 90Y-microsphere PET respectively for tumor (a) and normal liver (b). Left: scatter plots. The dotted lines stand for the linear regression (ρ: Pearson’s correlation). Right: Bland-Altman diagrams. The dashed lines indicate the mean bias (grayed is the 95% confidence interval) and the plain lines the 95% limits of agreement. DT, mean dose to the tumor; DNL, mean dose to the normal liver
Fig. 3
Fig. 3
Difference in dose distribution between normalized 99mTc-MAA SPECT and 90Y-microsphere PET. a Absolute mean dose difference according to the catheter position. Dice coefficient similarity according to the catheter position for 50 Gy isodoses (b) and 100 Gy isodoses (c). Asterisks (*) indicate P values that remained significant in multivariate analysis
Fig. 4
Fig. 4
50 Gy (a), 100 Gy (b), and 150 Gy (c) isodose Dice coefficient similarity according to the catheter tip distance from major artery bifurcation at treatment. Asterisk (*) indicates P value that remained significant in multivariate analysis

References

    1. Wondergem M, Smits ML, Elschot M, et al. 99mTc macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. J Nucl Med. 2013;54:1294–1301. doi: 10.2967/jnumed.112.117614. - DOI - PubMed
    1. Garin E, Lenoir L, Rolland Y, et al. Dosimetry based on 99mTcmacroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med. 2012;53:255–263. doi: 10.2967/jnumed.111.094235. - DOI - PubMed
    1. Haste P, Tann M, Persohn S, et al. Correlation of technetium-99m macroaggregated albumin and Yttrium-90 glass microsphere biodistribution in hepatocellular carcinoma: a retrospective review of pretreatment single photon emission CT and posttreatment positron emission tomography/CT. J Vasc Interv Radiol. 2017;28:722–730. doi: 10.1016/j.jvir.2016.12.1221. - DOI - PubMed
    1. Song YS, Paeng JC, Kim HC, et al. PET/CT-based dosimetry in 90Y-microsphere selective internal radiation therapy: single cohort comparison with pretreatment planning on (99m)Tc-MAA imaging and correlation with treatment efficacy. Medicine. 2015;94:e945. doi: 10.1097/MD.0000000000000945. - DOI - PMC - PubMed
    1. Gnesin S, Canetti L, Adib S, et al. Partition model based 99mTc-MAA SPECT/CT predictive dosimetry compared to 90Y TOF PET/CT post-treatment dosimetry in radioembolisation of hepatocellular carcinoma: a quantitative agreement comparison. J Nucl Med. 2016;57:1672–1678. doi: 10.2967/jnumed.116.173104. - DOI - PubMed